Following is our
new address and
phone number:


Tamir Biotechnology, Inc.
12625 High Bluff Dr.
Suite 113
San Diego, CA 
92130

732 823-1003
     
   

November 29, 2010
New Discovery May Offer Cure for Human Papillomavirus (HPV)

September 28, 2010

New Discovery Targets Cytomegalovirus (CMV)

August 10, 2010
New Hope in Finding Cure for Yellow Fever


July 21, 2010
Tamir Reports Positive Effect Against SARS Virus

July 19, 2010
Tamir's Compounds Show Remarkable Results Against Dengue Virus

07/16/10 Tommy G. Thompson, Former Secretary of Health and Human Services, Appointed to Tamir Biotechnology, Inc. as Special Advisor to CEO and Chairman of Oncology and Anti-Viral Business Development Advisory Committee


07/06/10 Tamir Biotechnology, Inc. Announces Selection of CRO

05/03/10 Tamir Biotechnology Filed Resale Registration Statement as Required by the Investor Rights Agreement in a Previously Closed Private Placement

10/20/09 Alfacell Corporation Announces Closing of $3.25 Million Private Placement

12/12/08 Alfacell Announces Management Update


12/10/08 Alfacell Reports Financial Results for First Quarter of Fiscal 2009

12/10/08 Alfacell's ONCONASE(R) and R-Amphinase Show Anti-Tumor Activity in Chronic Lymphocytic Leukemia and Acute Myeloblastic Leukemia Cells


10/23/08 Alfacell Receives Going Concern Audit Opinion

10/14/08 Alfacell Reports Fiscal Fourth Quarter and Full Year 2008 Financial Results

10/09/08 Paper in Cell Cycle Reports Alfacell's ONCONASE(R) Targets siRNA


07/21/08 Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacell's ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines

07/15/08 Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel

06/09/08 Alfacell Reports Financial Results for Third Quarter of Fiscal 2008

06/04/08 Alfacell to Host Fiscal Third Quarter 2008 Financial Results Conference Call and Webcast

05/29/08 BellwetherReport.com Analyst Report on KOSN, ACEL, SHLD and SSCC


05/28/08 Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial

04/28/08 Alfacell Announces Retirement of Chief Executive Officer

04/14/08 Alfacell's ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment

04/03/08 BenchmarkJournal.com Sector Analysis for ACEL, MECA, SANM and CDS

04/02/08 Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program

03/07/08 Alfacell Reports Financial Results for Second Quarter of Fiscal 2008

02/29/08 Alfacell to Host Fiscal Second Quarter 2008 Financial Results Conference Call and Webcast


02/21/08 Pre-Clinical Data Show Intracellular Pathways Affected by ONCONASE(R)

01/30/08 Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program

01/22/08 Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement With BL&H for South Korea, Taiwan and Hong Kong

01/18/08 Alfacell Announces ONCONASE(R) Purchase and Supply Agreement with Scientific Protein Laboratories

01/17/08 Alfacell Appoints David Sidransky Chairman of the Board of Directors

12/10/07 Alfacell Reports Financial Results for First Quarter of Fiscal 2008

12/03/07 Alfacell to Host Fiscal First Quarter 2008 Financial Results Conference Call and Webcast

10/30/07 Alfacell's ONCONASE(R) Shows Promise as Radiation Sensitizer for Lung Cancer Treatment

10/29/07 Alfacell Corporation to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference


10/25/07 Alfacell to Host Webinar on RNA Interference-Like Mechanics of RNase Therapeutics on Nov. 29

10/15/07 Alfacell Reports Fiscal Fourth Quarter and Year-End 2007 Financial Results

10/05/07 Alfacell to Host Fiscal Fourth Quarter and Year-End 2007 Financial Results Conference Call and Webcast


10/04/07 Alfacell to Present at BIO InvestorForum 2007

09/19/07 Alfacell Corporation to Present at UBS Global Life Sciences Conference

09/12/07 Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program

08/23/07 Paper in Advances in Experimental Medicine and Biology Reports Alfacell's ONCONASE(R) Enhances Effect of Radiation in Non-Small Cell Lung Cancer




© 1998-2010, Tamir Biotechnology, Inc., formerly Alfacell Corporation

12625 High Bluff Dr.
Suite 113
San Diego, CA 92130

732 823-1003
www.TamirBio.com
info@tamirbio.com
Disclaimer